MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced that ...

MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT ®, Inc. (Nasdaq: XENT), a global ear, nose and throat (“ENT”) medical technology leader dedicated to transforming patient care, today announced the U ...

MENLO PARK, Calif.--(BUSINESS WIRE)-- Intersect ENT®, Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced results from a ...

The "Sinus Dilation Devices Market by Product (Balloon Dilation, Stents, Endoscope (Rhinoscopy, Sinoscopy), Handheld), Procedure (Standalone, Hybrid), Patient Type, Patient Care Setting (ENT, Clinic, ...

Medtronic launched its NuVent Eustachian tube dilation balloon, which gives surgeons an outpatient option for some ear, nose and throat conditions. Medtronic said Feb. 28 the NuVent balloon is ...

With fall allergies upon us, and cold and flu season starting, more than one in eight adults will experience chronic sinus infection – sinusitis – this year. The result is nasal congestion, drainage, ...

Intersect ENT, which focuses on products for patients with ear, nose and throat conditions, said a study dubbed ASCEND that evaluated its drug-coated sinus balloon for dilation of the frontal sinus ...

The Federal Trade Commission says Medtronic can move forward with a proposed acquisition so long as the company promptly divests a subsidiary that makes certain medical devices used in sinus ...

Acclarent, an Irvine-based maker of minimally invasive technologies for the ears, nose and throat sector, is being sold by parent Johnson & Johnson for $275 million to Integra LifeSciences Holdings ...

VenSure and Cube Join the Company’s Portfolio of Localized Drug Delivery Creating an Integrated Offering of ENT Technologies to Treat CRS As many as 1 in 8 adults in the United States suffer from CRS, ...